Pharmaceutical

Medicure Receives US FDA Fast Track Designation for MC-1 for PNPO Deficiency

WINNIPEG, MB / ACCESSWIRE / April 23, 2024 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company focused…

3 months ago

Laxxon Medical to Participate in the World Orphan Drug Congress USA 2024

NEW YORK, NY / ACCESSWIRE / April 23, 2024 / Laxxon Medical, a leading 3D screen printing platform technology company,…

3 months ago

Evotec SE appoints Dr Christian Wojczewski as Chief Executive Officer

HAMBURG, GERMANY / ACCESSWIRE / April 23, 2024 / The Supervisory Board of Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX,…

3 months ago

Newtopia Now, August Launch Event from New Hope Network, Unveils First Reveal of Neighborhood Concept

Focus on curated brand-to-buyer experience and enhanced matchmaking offers opportunities for deep relationship building, connecting brands to key retailers, press…

3 months ago

Red Light Holland Initiates Psilocybin Extraction Phase with PharmAla Following Successful Testing and Preparation by CCrest Labs

Toronto, Ontario--(Newsfile Corp. - April 23, 2024) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light…

3 months ago

CNS Pharmaceuticals to Present at the LSX World Congress 2024

Presentation on Monday, April 29th at 4:15 PM (GMT+1)HOUSTON, TX / ACCESSWIRE / April 23, 2024 / CNS Pharmaceuticals, Inc.…

3 months ago

New Resources Explain How Court Ruling Improves Insured Consumer Access to Medications

English and Spanish materials include information on a 2023 court decision that requires health plans to count copay assistance towards…

3 months ago

Tribun Health, Winner of the I-Nov Competition of Bpifrance, Obtains Funding of Over €600,000 for Its Pathomix Project

PARIS, FRANCE / ACCESSWIRE / April 23, 2024 / Tribun Health, a major player in software solutions for digital pathology,…

3 months ago

Nutriband Inc. Signs Exclusive Supplier Agreement with Major Sports Brand Licensee Fit for Life Group

ORLANDO, FL / ACCESSWIRE / April 23, 2024 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), today announced that following its engagement by Fit…

3 months ago

Tarsus Strengthens Financial Position and Refinances Existing Debt with $200 Million Non-dilutive Financing Commitment from Pharmakon

IRVINE, Calif., April 23, 2024 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission is to focus on unmet…

3 months ago